El Rebetol Genérico se utiliza en el tratamiento de la infección de hepatitis C en algunos pacientes cuando se usa combinado con interferón. Más informaión »
Nuestra página de facturación está certificada por:
GS-7977 with interferon/ribavirin cures most treatment-naive hepatitis C ... - aidsmap
GS-7977 with interferon/ribavirin cures most treatment-naive hepatitis C .
Medivir: Interim Report, 1 January -- 31 March 2012 - MarketWatch (press release)
Medivir: Interim Report, 1 January -- 31 March 2012MarketWatch (press release)Apart from interferon and ribavirin-free combination trials on TMC435 in phase II, this collaboration now also covers a phase III program Medivir opened 2012 with continued stable sales of Rx pharmaceuticals.
Experts Discuss DAAs for Difficult-To-Treat Hep C Patients - Infectious Disease Special Edition
Infectious Disease Special EditionExperts Discuss DAAs for Difficult-To-Treat Hep C PatientsInfectious Disease Special EditionOverall, the new reports revealed the following: Cirrhotic patients who previously received the standard two-drug therapy and then received telaprevir in combination with pegylated interferon (Peg-IFN) and ribavirin had improved SVR compared with .
Twelve Weeks of GS-7977 Eliminates HCV as Well as 24 Weeks - Medscape
Twelve Weeks of GS-7977 Eliminates HCV as Well as 24 WeeksMedscapeMay 2, 2012 (Barcelona, Spain) — Twelve weeks of GS-7977 (Gilead Sciences) plus pegylated interferon (pegIFN) and ribavirin was as effective as 24 weeks of treatment in eliminating hepatitis C virus (HCV) genotype 1.
CDC delivers gift to hep C drug makers - FiercePharma